Negative regulation of dendrite development

pathway activity — cross-omics
GO:2000171Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of dendrite development pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are BCL11A, CHERP, and MED26, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of dendrite development activity versus BCL11A in LSCC (Pearson r = 0.65).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCBCL11A →+1.270+1.251<.001<.00136
LSCCCHERP →+0.492+0.699<.001<.00135
LSCCMED26 →+0.287+0.687<.001<.00135
HNSCMIPEPP3 →+0.744+0.698<.001<.00135
LSCCCUX1 →+0.540+0.902.009<.00126
HNSCMAP3K14-AS1 →+0.354+0.588.005.00235
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:2000171 vs BCL11A — LSCC

Per-sample scatter of Negative regulation of dendrite development activity vs BCL11A in LSCC.

Explore this scatter interactively →

Exploration